Met Life Investment Management, LLC Relay Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $20.1 Billion
  • Q3 2025

A detailed history of Met Life Investment Management, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 63,215 shares of RLAY stock, worth $418,483. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63,215
Previous 75,117 15.84%
Holding current value
$418,483
Previous $259,000 27.03%
% of portfolio
0.0%
Previous 0.0%

Shares

40 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
SELL
$3.22 - $5.22 $38,324 - $62,128
-11,902 Reduced 15.84%
63,215 $329,000
Q2 2025

Aug 13, 2025
BUY
$2.0 - $3.49 $19,690 - $34,359
9,845 Added 15.08%
75,117 $259,000
Q1 2025

May 14, 2025
SELL
$2.62 - $4.92 $23,302 - $43,758
-8,894 Reduced 11.99%
65,272 $171,000
Q4 2024

Feb 13, 2025
BUY
$4.12 - $6.8 $67,885 - $112,043
16,477 Added 28.56%
74,166 $305,000
Q2 2024

Aug 13, 2024
BUY
$5.9 - $8.02 $68,652 - $93,320
11,636 Added 25.27%
57,689 $376,000
Q1 2024

May 14, 2024
BUY
$7.5 - $12.07 $345,397 - $555,859
46,053 New
46,053 $382,000
Q3 2023

May 09, 2024
BUY
$8.24 - $12.97 $11,692 - $18,404
1,419 Added 3.18%
46,053 $387,000
Q2 2023

Apr 29, 2024
BUY
$9.99 - $18.27 $460,069 - $841,388
46,053 New
46,053 $578,000
Q2 2023

Aug 10, 2023
BUY
$9.99 - $18.27 $14,175 - $25,925
1,419 Added 3.18%
46,053 $578,000
Q1 2023

May 09, 2024
BUY
$15.0 - $22.76 $669,510 - $1.02 Million
44,634 New
44,634 $735 Million
Q4 2022

May 10, 2024
BUY
$14.16 - $24.02 $54,048 - $91,684
3,817 Added 9.35%
44,634 $666,000
Q4 2022

Mar 22, 2023
BUY
$14.16 - $24.02 $54,048 - $91,684
3,817 Added 9.35%
44,634 $666,000
Q4 2022

Feb 15, 2023
BUY
$14.16 - $24.02 $54,048 - $91,684
3,817 Added 9.35%
44,634 $666,000
Q3 2022

May 10, 2024
BUY
$18.07 - $31.37 $51,589 - $89,561
2,855 Added 7.52%
40,817 $913,000
Q3 2022

Jun 14, 2023
SELL
$18.07 - $31.37 $68,973 - $119,739
-3,817 Reduced 8.55%
40,817 $913,000
Q3 2022

Mar 22, 2023
BUY
$18.07 - $31.37 $51,589 - $89,561
2,855 Added 7.52%
40,817 $913,000
Q3 2022

Nov 14, 2022
BUY
$18.07 - $31.37 $51,589 - $89,561
2,855 Added 7.52%
40,817 $913,000
Q2 2022

Jun 20, 2023
SELL
$13.31 - $34.88 $88,804 - $232,719
-6,672 Reduced 14.95%
37,962 $635,000
Q1 2022

May 10, 2024
BUY
$20.26 - $32.36 $769,110 - $1.23 Million
37,962 New
37,962 $1.14 Million
Q1 2022

Jun 20, 2023
SELL
$20.26 - $32.36 $135,174 - $215,905
-6,672 Reduced 14.95%
37,962 $1.14 Million
Q1 2022

Mar 22, 2023
BUY
$20.26 - $32.36 $274,239 - $438,024
13,536 Added 55.42%
37,962 $1.14 Million
Q1 2022

May 12, 2022
BUY
$20.26 - $32.36 $274,239 - $438,024
13,536 Added 55.42%
37,962 $1.14 Million
Q4 2021

May 17, 2024
BUY
$26.0 - $37.03 $82,082 - $116,903
3,157 Added 14.84%
24,426 $750,000
Q4 2021

Jun 21, 2023
SELL
$26.0 - $37.03 $525,408 - $748,302
-20,208 Reduced 45.27%
24,426 $750,000
Q4 2021

Mar 22, 2023
BUY
$26.0 - $37.03 $82,082 - $116,903
3,157 Added 14.84%
24,426 $750,000
Q4 2021

Feb 15, 2022
BUY
$26.0 - $37.03 $82,082 - $116,903
3,157 Added 14.84%
24,426 $750,000
Q3 2021

Jun 21, 2023
SELL
$29.75 - $37.99 $695,108 - $887,636
-23,365 Reduced 52.35%
21,269 $670,000
Q2 2021

May 17, 2024
BUY
$27.5 - $38.19 $102,107 - $141,799
3,713 Added 21.15%
21,269 $778,000
Q2 2021

Jun 21, 2023
SELL
$27.5 - $38.19 $642,537 - $892,309
-23,365 Reduced 52.35%
21,269 $778,000
Q2 2021

Mar 22, 2023
BUY
$27.5 - $38.19 $102,107 - $141,799
3,713 Added 21.15%
21,269 $778,000
Q2 2021

Aug 16, 2021
BUY
$27.5 - $38.19 $102,107 - $141,799
3,713 Added 21.15%
21,269 $778,000
Q1 2021

May 17, 2024
SELL
$32.52 - $61.53 $926,722 - $1.75 Million
-28,497 Reduced 61.88%
17,556 $606,000
Q1 2021

Jun 26, 2023
SELL
$32.52 - $61.53 $880,576 - $1.67 Million
-27,078 Reduced 60.67%
17,556 $607 Million
Q1 2021

Mar 22, 2023
BUY
$32.52 - $61.53 $124,421 - $235,413
3,826 Added 27.87%
17,556 $606,000
Q1 2021

May 14, 2021
BUY
$32.52 - $61.53 $124,421 - $235,413
3,826 Added 27.87%
17,556 $607,000
Q4 2020

Jun 22, 2023
SELL
$35.51 - $54.03 $1.1 Million - $1.67 Million
-30,904 Reduced 69.24%
13,730 $570,000
Q3 2020

May 24, 2024
SELL
$32.81 - $45.1 $1.06 Million - $1.46 Million
-32,323 Reduced 70.19%
13,730 $585 Million
Q3 2020

Jun 26, 2023
SELL
$32.81 - $45.1 $1.01 Million - $1.39 Million
-30,904 Reduced 69.24%
13,730 $584,000
Q3 2020

Mar 22, 2023
SELL
$32.81 - $45.1 $1.01 Million - $1.39 Million
-30,904 Reduced 69.24%
13,730 $584,000
Q3 2020

Nov 13, 2020
BUY
$32.81 - $45.1 $450,481 - $619,223
13,730 New
13,730 $585,000

Others Institutions Holding RLAY

# of Institutions
216
Shares Held
168M
Call Options Held
714K
Put Options Held
14.9K
View Full List

About Relay Therapeutics, Inc.

RLAY Quotes by TradingView
  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $796M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email